ANIX - Anixa Biosciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:

Balance Sheet

Annual
All numbers in thousands
Period Ending10/31/201810/31/201710/31/201610/31/2015
Current Assets
Cash And Cash Equivalents3,055.893,339.3742,488.3234,369.219
Short Term Investments2,0003,5007502,400
Net Receivables----
Inventory----
Other Current Assets----
Total Current Assets5,538.3727,013.943,400.3926,895.747
Long Term Investments----
Property, plant and equipment72.6752.701156.64443.456
Goodwill----
Intangible Assets837.51,745.7752,071.0712,396.367
Accumulated Amortization----
Other Assets----
Deferred Long Term Asset Charges----
Total Assets6,448.5428,812.4165,628.1079,335.57
Current Liabilities
Accounts Payable582.012480.324373.224374.703
Short/Current Long Term Debt----
Other Current Liabilities----
Total Current Liabilities1,265.111889.493468.756593.782
Long Term Debt----
Other Liabilities--4,171.8763,688.187
Deferred Long Term Liability Charges----
Minority Interest-251.377---
Negative Goodwill----
Total Liabilities1,265.111889.4934,640.6324,281.969
Stockholders' Equity
Misc. Stocks Options Warrants----
Redeemable Preferred Stock----
Preferred Stock----
Common Stock189.086166.02887.52487.249
Retained Earnings-170,170.209-156,174.184-151,165.193-146,148.765
Treasury Stock----
Capital Surplus175,415.931163,931.079152,051.144151,101.117
Other Stockholder Equity----
Total stockholders' equity5,434.8087,922.923973.4755,039.601
Net Tangible Assets4,597.3086,177.148-1,097.5962,643.234